Diaceutics Backs 2023 Views Despite First-Half Widened Loss;

By Michael Susin Diaceutics reported a widened pretax loss for the first half of 2023, driven by higher costs despite a revenue jump, but backed its...

Related Keywords

Michael Susin , Ryan Keeling , Peter Keeling , , Chief Executive Peter Keeling , Chief Innovation Officer Ryan Keeling , Article Normal , Healthcare Life Sciences , Healthcare Support Services , Diagnostic Medical Research Services , Financial Performance , Earnings , Management , Management Moves , Corporate Industrial News , Senior Level Management , Content Types , Factiva Filters , C Amp Ampe Executive News Filter , C Amp Ampe Industry News Filter , Synd , Diaceutics , Dxrx Ln , Uk Dxrx , Corporate , Industrial News , Healthcare , Life Sciences , Diagnostic , Medical Research Services ,